Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F1QAC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,215
Award facts
- Contract value 100% obligated
- $20,215.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $20.2K delivery order to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 14, 2026, with performance taking place at the contractor's headquarters in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral medication used in the treatment of HIV, reflecting the Defense Logistics Agency Medical Supply Chain's ongoing pharmaceutical procurement needs to support military healthcare systems and beneficiaries.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. AmerisourceBergen, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor for federal military and veteran healthcare programs, maintaining a substantial contract portfolio that enables the delivery of brand-name and generic medications, specialty drugs, and medical supplies across multiple therapeutic domains. The non-set-aside status of this award demonstrates the contractor's continued competitive capability to fulfill essential federal medical procurement requirements.
Quick answers
Who was awarded contract SPE2DR26F1QAC?
SPE2DR26F1QAC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F1QAC worth?
The government has obligated $20,215 on SPE2DR26F1QAC.
Is contract SPE2DR26F1QAC an order under another contract?
Yes. SPE2DR26F1QAC is a delivery order under SPE2DR25D3108, an indefinite delivery contract.
Was contract SPE2DR26F1QAC competed?
The extent of competition for SPE2DR26F1QAC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award